News

PipelineReview.com23h
Zhimeng Biopharma’s Next-Generation KCNQ2/3 Potassium Channel Opener Receives Clinical Trial Approval for ALS Phase 2/3 Study
SHANGHAI, China I July 9, 2025 I Shanghai Zhimeng Biopharma, Inc. ("Zhimeng Biopharma"), a clinical-stage biopharmaceutical company dedicated to innovative ...
The Citizen20h
Poll: How Americans think the government should respond to natural disasters
February and June polls found Americans generally have high confidence in the National Weather Service and their local ...